Exploring the Case for Eminent Domain of Hepatitis C Virus Treatment Patents

Mattingly T. Joseph II; Heil Emily L.; Hoke Kathleen S.

首页> 外文期刊>Journal of health care for the poor and underserved >Exploring the Case for Eminent Domain of Hepatitis C Virus Treatment Patents

【24h】

Exploring the Case for Eminent Domain of Hepatitis C Virus Treatment Patents

机译：探索丙型肝炎病毒治疗专利的突出域

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Hepatitis C virus (HCV) is a silent epidemic affecting millions of patients and represents the leading indication for liver transplantation in the United States and worldwide. New direct-acting antiviral agents offer the potential to cure patients infected with HCV but it comes at a staggering cost. Given the recent attention to these high-priced HCV therapies and the impact treating individuals with HCV is having on drug expenditures in the United States, there may be a need to revisit drug patent laws and the options the federal government has to ensure patient access to care.

机译：丙型肝炎病毒（HCV）是一种影响数百万患者的沉默流行，并代表了美国和全球肝移植的主要迹象。新的直接作用抗病毒剂提供治愈HCV患者的潜力，但它以惊人的成本。鉴于最近对这些高价HCV疗法的关注和HCV的影响疗法在美国有毒品支出上，可能需要重新审视药物专利法，联邦政府必须确保患者进入的备选方案关心。

著录项

来源
《Journal of health care for the poor and underserved》 |2017年第2期|共5页
作者
Mattingly T. Joseph II; Heil Emily L.; Hoke Kathleen S.;
展开▼
作者单位

Univ Maryland Sch Pharm Dept Pharm Practice &

Sci Baltimore MD 21201 USA;

Univ Maryland Med Ctr Dept Pharm College Pk MD 20742 USA;

Univ Maryland Francis King Carey Sch Law College Pk MD 20742 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类保健组织与事业（卫生事业管理）;
关键词
Hepatitis C; managed care; health care policy; infectious diseases; law; legal/regulatory issues;

机译：丙型肝炎;管理保健;医疗保健政策;传染病;法律;法律/监管问题;

相似文献

外文文献
中文文献
专利

1. Exploring the Case for Eminent Domain of Hepatitis C Virus Treatment Patents [J] . Mattingly T. Joseph II, Heil Emily L., Hoke Kathleen S. Journal of health care for the poor and underserved . 2017,第2期

机译：探索丙型肝炎病毒治疗专利的突出域
2. Biomedical Patents and the Public's HealthIs There a Role for Eminent Domain? [J] . Aaron S JAMA: the Journal of the American Medical Association . 2006,第4期

机译：生物医学专利与公众健康杰出领域是否有作用？
3. Conserved functional domains and a novel tertiary interaction near the pseudoknot drive translational activity of hepatitis C virus and hepatitis C virus-like internal ribosome entry sites. [J] . Easton Laura E., Locker Nicolas, Lukavsky Peter J. Nucleic Acids Research . 2009,第16期

机译：保守的功能域和假结附近的新型三级相互作用驱动丙型肝炎病毒和丙型肝炎病毒样内部核糖体进入位点的翻译活性。
4. HLA-C gene in Hepatitis C Virus infected Patients in Egypt, to estimate the relation between HLA-C gene and Interferon/Ribavirin as treatment for hepatitis C virus [C] . SHADEN MUAWIA HANAFY, AMAL AHMED ABBAS, SAFY KABEEL ALY MANSOUR International Conference on Cellular and Molecular Biology, Biophysics and Bioengineering . 2015

机译：HLA-C基因在丙型肝炎病毒中感染埃及患者，估计HLA-C基因和干扰素/利巴韦林与丙型肝炎病毒治疗的关系
5. Impacts of Hepatitis C Virus Infection Treatment for Patients in Treatment for Opioid Use Disorder [D] . Severe, Brooke. 2019

机译：丙型肝炎病毒感染治疗对患者的影响对阿片类药物使用障碍的影响
6. Conserved functional domains and a novel tertiary interaction near the pseudoknot drive translational activity of hepatitis C virus and hepatitis C virus-like internal ribosome entry sites [O] . Laura E. Easton, Nicolas Locker, Peter J. Lukavsky 2009

机译：保守的功能域和假结附近的新型三级相互作用驱动丙型肝炎病毒和丙型肝炎病毒样内部核糖体进入位点的翻译活性
7. Conserved functional domains and a novel tertiary interaction near the pseudoknot drive translational activity of hepatitis C virus and hepatitis C virus-like internal ribosome entry sites [O] . Easton, Laura E., Locker, Nicolas, Lukavsky, Peter J. 2009

机译：保守的功能域和假结附近的新型三级相互作用驱动丙型肝炎病毒和丙型肝炎病毒样内部核糖体进入位点的翻译活性
8. Compounds, Methods and Compositions Useful for the Treatment of Bovine Viral Diarrhea Virus (BVDV) Infection and Hepatitis C Virus (HCV) Infection. [R] . Dykstra, C. C., Givens, M. D., Stringfellow, D. A., 2005

机译：可用于治疗牛病毒性腹泻病毒（BVDV）感染和丙型肝炎病毒（HCV）感染的化合物，方法和组合物。

Exploring the Case for Eminent Domain of Hepatitis C Virus Treatment Patents

摘要

著录项

相似文献

相关主题

期刊订阅